title: Rosiglitazone: trials, tribulations and termination.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Krentz
mesh_terms: D018849:Controlled Clinical Trials as Topic; D017277:Drug Approval / Q000266:history* / Q000379:methods; D005060:Europe; D049674:History, 21st Century; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals / Q000266:history*; D045162:Thiazolidinediones / Q000009:adverse effects*; D014481:United States
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone